Great Lakes Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-84,467
Closed -$961K 885
2024
Q3
$961K Sell
84,467
-2,186
-3% -$21.9K 0.01% 585
2024
Q2
$619K Buy
86,653
+21,370
+33% +$163K 0.01% 622
2024
Q1
$437K Sell
65,283
-1,912
-3% -$13.2K ﹤0.01% 634
2023
Q4
$437K Sell
67,195
-86,814
-56% -$560K ﹤0.01% 623
2023
Q3
$1.45M Sell
154,009
-18,753
-11% -$226K 0.01% 485
2023
Q2
$2.41M Sell
172,762
-22,650
-12% -$386K 0.02% 430
2023
Q1
$3.67M Buy
+195,412
New +$3.21M 0.03% 418

Other funds holding CDMO

Great Lakes Advisors's CDMO Position: Q4 2024 in Review

Great Lakes Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 84,467 shares — an estimated $961K sold.

Great Lakes Advisors first reported a position in CDMO in Q1 2023 and held it in 7 quarters. The position peaked at $3.67M in Q1 2023. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

  • Great Lakes Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Great Lakes Advisors sold 84,467 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $961K.
  • Great Lakes Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2023 and held it in 7 quarters.
  • Great Lakes Advisors's Avid Bioservices, Inc. Common Stock position peaked at $3.67M in Q1 2023.
  • 195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Great Lakes Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.